Radboud UMC

Running trials

• Recruiting

  Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

  NCT07621718· Phase 3· Source

• Recruiting

  Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

  NCT07645625· Phase 4· Source

• Recruiting

  Hypofractionated Definitive Chemoradiotherapy for Oesophageal Cancer

  NCT07632079· Phase 2· Source

• Recruiting

  Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

  NCT07556887· Source

• Recruiting

  Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery

  NCT07351149· Source

• Recruiting

  OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes

  NCT06476119· Source

• Recruiting

  The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

  NCT07038304· Phase 2· Source

• Not yet recruiting

  FET-PET-Guided Management of Pseudoprogression in Glioblastoma

  NCT06480721· Source

• Recruiting

  Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer

  NCT06122584· Phase 3· Source

• Recruiting

  Dutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS

  NCT05900271· Source

• Recruiting

  Dutch Registry of Pediatric Cardiac Arrest

  NCT06938009· Source

• Active, not recruiting

  Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

  NCT05817942· Source

• Recruiting

  A Study on the Effects of Left Ventricular Unloading in the Setting of VA ECMO Support

  NCT05913622· Source

• Recruiting

  Prediction Models for Complications After CRT in Esophageal Cancer

  NCT06366828· Source

• Recruiting

  Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours

  NCT05752552· Phase 1· Source

• Recruiting

  Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer

  NCT05600127· Phase 2· Source

• Active, not recruiting

  Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)

  NCT04597671· Phase 3· Source

• Active, not recruiting

  The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients

  NCT05741944· Source

• Active, not recruiting

  Pullback Pressure Gradient (PPG) Global Registry

  NCT04789317· Source

• Recruiting

  The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

  NCT04075305· Source

• Recruiting

  Cardiopulmonary Toxicity of Thoracic Radiotherapy

  NCT03978377· Source

• Recruiting

  Prospective Data Collection Initiative on Colorectal Cancer

  NCT02070146· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Gastric and esophageal cancer4 recruiting
• Lung cancer3 recruiting
• Prostate cancer3 recruiting
• Bladder cancer2 recruiting
• Colorectal cancer2 recruiting
• Pancreatic cancer2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Cervical cancer1 recruiting
• Childhood cancers1 recruiting
• Depression1 recruiting
• Glioblastoma1 recruiting
• Head and neck cancer1 recruiting
• High blood pressure1 recruiting
• Liver and biliary tract cancer1 recruiting
• Pulmonary arterial hypertension1 recruiting
• Stroke1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer

  NCT06516510· Early phase 1· Source

• Completed

  Role of Adrenaline in in the Inflammatory Response in Diabetes

  NCT05990933· Source

• Completed

  The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After Pancreatoduodenectomy

  NCT05709197· Source

• Completed

  Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region

  NCT05482880· Source

• Completed

  Exploratory Drug Interaction Study Between SMIs and DOACs

  NCT05732350· Source

• Completed

  Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

  NCT04437303· Phase 4· Source

• Completed

  Reduced Anticoagulation Targets in ECLS (RATE)

  NCT04536272· Phase 3· Source

• Terminated

  NOLA (NeuWave Observational Liver Ablation) Registry

  NCT04107766· Source

• Terminated

  TITRATE (inducTIon for acuTe ulceRATivE Colitis)

  NCT03937609· Phase 4· Source

• Completed

  Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy

  NCT04657120· Source

• Completed

  Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry

  NCT03048825· Phase 3· Source

• Completed

  Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy

  NCT03387761· Phase 1· Source

• Completed

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· Phase 3· Source

• Completed

  Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases

  NCT02162563· Phase 3· Source